January 27, 2021
Year in Review for Drug and Device Advertising and Promotion – Lessons Learned from 2020 FDA Enforcement Letters and Other Key Developments
January 19, 2021
Rounding Out 2020: Overview of Recent Statutory and Regulatory Changes to Medicare and Medicaid Reimbursement
January 12, 2021
The New Frontier in Managed Care: An Overview of the Newly Passed Federal Surprise Billing Legislation
January 7, 2021
Recalculating: Major Stark, Anti-Kickback and CMP Final Rule Changes Are Taking Us in a New Direction
December 16, 2020
The World Changed in 2020 – What This Means for Healthcare Fraud Enforcement and You
December 9, 2020
2nd Annual Financial Services Summit
December 9, 2020
COVID-19’s Impact on the Senior Care Industry: A Discussion on Crisis Management in the Face of Litigation and Enforcement Activity
December 3, 2020
Fintech, Digital Currency and Secure Payments: The View from the Central Banks
November 24, 2020
Maintaining Orphan Drug Status Through Product Approval – Recent Court Decision May Enhance Predictability for Drug Developers and Investors
November 17, 2020
International Trade Post-Election: A Look at What’s Ahead in 2021
November 12, 2020
Federal M&A Outlook 2021